These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12935941)

  • 21. Emerging Insights for Better Delivery of Chemicals and Stem Cells to the Brain.
    Baig AM
    ACS Chem Neurosci; 2017 Jun; 8(6):1119-1121. PubMed ID: 28367623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of therapeutic molecules into the CNS.
    Emborg ME; Kordower JH
    Prog Brain Res; 2000; 128():323-32. PubMed ID: 11105691
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ; de Boer AG
    Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurological disorders and the blood-brain barrier. Strategies and limitations for drug delivery to the brain].
    Domínguez A; Álvarez A; Suárez-Merino B; Goñi-de-Cerio F
    Rev Neurol; 2014 Mar; 58(5):213-24. PubMed ID: 24570360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport.
    Borlongan CV; Emerich DF
    Brain Res Bull; 2003 May; 60(3):297-306. PubMed ID: 12754091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M; Fortin D
    Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
    Ceña V; Játiva P
    Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
    [No Abstract]   [Full Text] [Related]  

  • 34. Delivery of therapeutics to the central nervous system.
    Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted drug delivery across the blood brain barrier in Alzheimer's disease.
    Rocha S
    Curr Pharm Des; 2013; 19(37):6635-46. PubMed ID: 23621533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD; Geldenhuys WJ
    Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide drug delivery into the central nervous system.
    Prokai L
    Prog Drug Res; 1998; 51():95-131. PubMed ID: 9949860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.